ICPT : Analysis & Opinions

  1. 4 Reasons Intercept Pharmaceuticals Should Be on Your Radar

    August 20, 2015
    Learn about Intercept Pharmaceuticals and what type of biopharmaceuticals it seeks to create. Understand four reasons why ...
  2. ETF Analysis: iShares NASDAQ Biotechnology

    August 7, 2015
    Learn about the iShares Nasdaq Biotechnology exchange-traded fund, which offers one of the most diversified ways of investing ...
  3. Intercept Pharmaceuticals Makes a Breakthrough

    July 7, 2015
    On June 30, 2015 Intercept Pharmaceuticals Inc announced two important regulatory milestones for its pipeline drug, obeticholic ...
  4. Will This Drug Beat Gilead to Market in NASH?

    May 22, 2015
    A race of sorts is on between Gilead Sciences (NASDAQ: GILD) and Intercept Pharmaceuticals (NASDAQ: ICPT). In a bid to be ...
  5. Meet The 5 Companies Loving Obamacare

    November 4, 2014
  6. ViroPharma and Other Biotech Stocks Recommended by Oppenheimer ...

    June 24, 2013
    Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new ...
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!